IL4 and Alzheimer disease: Biphasic cutaneous immune response was observed in AD.[42] In the initiation acute phase, IL-4 production by Th2 is predominant; in the late and chronic phase, interferon-γ production by Th1 is predominant.[42,43] The effect of treatment being given to AD patients has been well investigated in epidermal immunity.